Apyx Medical Corp Proceeds from Sale and Maturity of Marketable Securities
Apyx Medical Corp (APYX) reported Proceeds from Sale and Maturity of Marketable Securities of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-31.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities · last filed 2021-03-31
- Apyx Medical Corp proceeds from sale and maturity of marketable securities for the quarter ending 2020-12-31 was $0.00.
- Apyx Medical Corp proceeds from sale and maturity of marketable securities for the quarter ending 2020-09-30 was $0.00.
- Apyx Medical Corp proceeds from sale and maturity of marketable securities for the quarter ending 2020-06-30 was $0.00, a 100.00% decline year-over-year.
- Apyx Medical Corp proceeds from sale and maturity of marketable securities for the quarter ending 2020-03-31 was $0.00, a 100.00% decline year-over-year.
- Apyx Medical Corp proceeds from sale and maturity of marketable securities for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- Apyx Medical Corp proceeds from sale and maturity of marketable securities for fiscal 2019 was $80.73M, a 213.40% increase from fiscal 2018.
- Apyx Medical Corp proceeds from sale and maturity of marketable securities for fiscal 2018 was $25.76M.
- Apyx Medical Corp proceeds from sale and maturity of marketable securities for fiscal 2017 was $0.00.
| Period end | Proceeds from Sale and Maturity of Marketable Securities 3 month | Proceeds from Sale and Maturity of Marketable Securities 6 month | Proceeds from Sale and Maturity of Marketable Securities 9 month | Proceeds from Sale and Maturity of Marketable Securities 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $0.00 derived: sum of 2 quarters · filed 2021-03-31 | $0.00 derived: sum of 3 quarters · filed 2021-03-31 | $0.00 10-K · filed 2021-03-31 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $0.00 derived: sum of 2 quarters · filed 2020-11-09 | $0.00 10-Q · filed 2020-11-09 | $0.00 derived: sum of 4 quarters · filed 2021-03-31 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $0.00 10-Q · filed 2020-08-10 | $0.00 derived: sum of 3 quarters · filed 2021-03-31 | $0.00 derived: sum of 4 quarters · filed 2021-03-31 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-11 | $0.00 derived: sum of 2 quarters · filed 2021-03-31 | $0.00 derived: sum of 3 quarters · filed 2021-03-31 | $40.88M derived: sum of 4 quarters · filed 2021-03-31 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $0.00 derived: sum of 2 quarters · filed 2021-03-31 | $40.88M derived: sum of 3 quarters · filed 2021-03-31 | $80.73M 10-K · filed 2021-03-31 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $40.88M derived: sum of 2 quarters · filed 2020-11-09 | $80.73M 10-Q · filed 2020-11-09 | $106.48M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $40.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $80.73M 10-Q · filed 2020-08-10 | $106.48M derived: sum of 3 quarters · filed 2020-08-10 | $106.48M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $39.84M 10-Q · filed 2020-05-11 | $65.60M derived: sum of 2 quarters · filed 2020-05-11 | $65.60M derived: sum of 3 quarters · filed 2020-05-11 | $65.60M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $25.76M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-31 | $25.76M derived: sum of 2 quarters · filed 2020-03-31 | $25.76M derived: sum of 3 quarters · filed 2020-03-31 | $25.76M 10-K · filed 2020-03-31 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-15 | $0.00 derived: sum of 2 quarters · filed 2019-11-15 | $0.00 10-Q · filed 2019-11-15 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2019-08-07 | $0.00 10-Q · filed 2019-08-07 | ||
| 2018-03-31 | $0.00 10-Q/A · filed 2020-05-08 | |||
| 2017-12-31 | $0.00 10-K · filed 2020-03-31 | |||
| 2016-12-31 | $0.00 10-K · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |